Concord Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NSEI:CONCORDBIO Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
22 Sep 24	Sell₹10,844,008	Prakash Sajnani	Individual	5,000	₹2,168.80
22 Sep 24	Sell₹2,109,400	Chandrashekhar Chawan	Individual	1,000	₹2,109.40
02 Sep 24	Sell₹5,204,357	Devang Bhatt	Individual	3,000	₹1,734.79
12 Jun 24	Sell₹14,404,020	Kanishka Kapoor	Individual	10,000	₹1,440.40
26 Feb 24	Sell₹5,998,089	Rajendra Modi	Individual	4,000	₹1,499.52
26 Feb 24	Sell₹2,984,731	Raksha Modi	Individual	2,000	₹1,492.37
23 Feb 24	Sell₹1,444,901	Chandrashekhar Chawan	Individual	1,000	₹1,444.90
23 Feb 24	Sell₹2,933,040	Raksha Modi	Individual	2,000	₹1,466.52

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CONCORDBIO?
Owner Type	Number of Shares	Ownership Percentage
General Public	9,306,230	8.9%
Institutions	15,576,704	14.9%
Private Companies	31,115,073	29.7%
Individual Insiders	48,618,197	46.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 90.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
38.5%	Sudhir Vaid	40,230,828	₹88.2b	0%	no data
8.03%	Aryavir Jhunjhunwala Discretionary Trust	8,399,754	₹18.4b	0%	no data
8.03%	Aryaman Jhunjhunwala Discretionary Trust	8,399,754	₹18.4b	0%	no data
8.03%	Nishtha Jhunjhunwala Discretionary Trust	8,399,732	₹18.4b	0%	no data
4.54%	Sudman Consultants Llp	4,752,000	₹10.4b	0%	no data
2.56%	Norges Bank Investment Management	2,683,394	₹5.9b	18.7%	0.01%
2.18%	The Vanguard Group, Inc.	2,281,490	₹5.0b	3.04%	no data
2%	Harcharan Singh	2,092,325	₹4.6b	0%	no data
1.93%	Amal Parikh	2,023,219	₹4.4b	0%	no data
1.91%	Max Life Insurance Company Limited, Asset Management Arm	2,002,009	₹4.4b	26.1%	3.14%
1.89%	Tata AIA Life Insurance Company Ltd., Asset Management Arm	1,980,578	₹4.3b	0%	2.03%
1.54%	Ravindra Dharamshi	1,606,432	₹3.5b	-20.4%	no data
1.11%	Chanakya Corporate Services Private Limited	1,163,833	₹2.6b	0%	no data
1.08%	Ankur Vaid	1,133,528	₹2.5b	0%	no data
1.04%	Invesco Ltd.	1,089,185	₹2.4b	-3.31%	0.01%
1.02%	HSBC Global Asset Management (UK) Limited	1,067,966	₹2.3b	-27%	0.01%
0.96%	Rupali Dharamshi	1,008,464	₹2.2b	0%	no data
0.8%	HSBC Global Asset Management (Hong Kong) Limited	837,277	₹1.8b	0%	0.49%
0.74%	Edelweiss Asset Management Limited	774,603	₹1.7b	-1.81%	0.23%
0.56%	DSP BlackRock Investment Managers Pvt. Ltd.	583,966	₹1.3b	0%	0.1%
0.48%	Baroda BNP Paribas Mutual Fund	496,959	₹1.1b	-25.4%	0.44%
0.35%	BlackRock, Inc.	361,793	₹793.2m	2.25%	no data
0.33%	UTI Asset Management Company Limited	344,690	₹755.7m	0%	0.03%
0.32%	PineBridge Investments LLC	333,164	₹730.4m	-0.28%	0.04%
0.2%	Ravi Kapoor	210,000	₹460.4m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/30 06:51
End of Day Share Price	2024/12/30 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Concord Biotech Limited is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
null null	Antique Stockbroking Ltd.
Rohit Bhat	Batlivala & Karani Securities India Pvt. Ltd.
Deepika Murarka	Choice Equity Broking Private Limited